San Antonio, TX
Website: UT Health San Antonio MD Anderson Cancer Center
Contact:
Epp Goodwin
210-450-5798
Linked In
You Tube
UT Health San Antonio MD Anderson Cancer Center
Trials at this location:
HCRN-BRE18-334
A Phase II circulating tumor DNA enriched, genomically directed post-neoadjuvant trial for patients with residual triple negative breast cancer (PERSEVERE)
Status: Open to Accrual
Facebook
Hoosier Cancer Research Network on Facebook
Linked In
You Tube
Twitter